Gonyer David A 4
4 · Evoke Pharma Inc · Filed Dec 11, 2020
Insider Transaction Report
Form 4
Evoke Pharma IncEVOK
Gonyer David A
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2020-12-09$0.40/sh+72,000$28,800→ 411,782 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-12-09−72,000→ 0 totalExercise: $0.40Exp: 2021-02-08→ Common Stock (72,000 underlying)
Footnotes (2)
- [F1]These options were scheduled to expire on February 8, 2021.
- [F2]These options were fully vested as of February 9, 2015.